Tumor perfusion enhancement by microbubbles ultrasonic cavitation reduces tumor glycolysis metabolism and alleviate tumor acidosis
Authors:
Open Access
- 18 July 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1424824
Abstract
The tumor microenvironment is increasingly acknowledged as a critical contributor to cancer progression, mediating genetic and epigenetic alterations. Beyond diverse cellular interactions from the microenvironment, physicochemical factors such as tumor acidosis also significantly affect cancer dynamics. Recent research has highlighted that tumor acidosis facilitates invasion, immune escape, metastasis, and resistance to therapies. Thus, noninvasive measurement of tumor acidity and the development of targeted interventions represent promising strategies in oncology. Techniques like contrast-enhanced ultrasound (CEUS) can effectively assess blood perfusion, while ultrasound-stimulated microbubble cavitation (USMC) has proven to enhance tumor blood perfusion. We therefore aimed to determine whether CEUS assesses tumor acidity and whether USMC treatment can modulate tumor acidity. Firstly, we tracked CEUS perfusion parameters in MCF7 tumor models and compared them with in vivo tumor pH recorded by pH microsensors. We found that the peak intensity and area under curve of tumor contrast-enhanced ultrasound correlated well with tumor pH. We further conducted USMC treatment on MCF7 tumor-bearing mice, tracked changes of tumor blood perfusion and tumor pH in different perfusion regions before and after the USMC treatment to assess its impact on tumor acidity and optimize therapeutic ultrasound pressure. We discovered that USMC with 1.0 Mpa significantly improved tumor blood perfusion and tumor pH. Furthermore, tumor vascular pathology and PGI2 assays indicated that improved tumor perfusion was mainly due to vasodilation rather than angiogenesis. More importantly, analysis of glycolysis-related metabolites and enzymes demonstrated USMC treatment can reduce tumor acidity by reducing tumor glycolysis. These findings support that CEUS may serve as a potential biomarker to assess tumor acidity and USMC is a promising therapeutic modality for reducing tumor acidosis.Keywords
This publication has 83 references indexed in Scilit:
- Ultrasound Imaging of Tumor Vascular CD93 with MMRN2 Modified Microbubbles for Immune Microenvironment PredictionAdvanced Materials, 2024
- Tumor lactic acid: a potential target for cancer therapyArchives of Pharmacal Research, 2023
- Ultrasound and microbubbles to beat barriers in tumors: Improving delivery of nanomedicineAdvanced Drug Delivery Reviews, 2021
- Ultrasound-induced biophysical effects in controlled drug deliveryScience China Life Sciences, 2021
- Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pHCancer and Metastasis Reviews, 2019
- Imaging with ultrasound contrast agents: current status and futureAbdominal Radiology, 2018
- Evaluations of Tumor Acidosis Within In Vivo Tumor Models Using Parametric Maps Generated with AcidoCEST MRIMolecular Imaging and Biology, 2015
- Cancer‐generated lactic acid: a regulatory, immunosuppressive metabolite?The Journal of Pathology, 2013
- The monocarboxylate transporter family—Role and regulationIUBMB Life, 2011
- Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activationInternational Journal of Cancer, 2011